| Literature DB >> 34803399 |
Hoda Shokri1, Ihab Ali2, Amr A Kasem1.
Abstract
PURPOSE: Transverse thoracic block is a new perioperative analgesic method for post-sternotomy discomfort. This study discusses the efficacy of an ultrasound-guided transversus thoracic muscle plane block (TTPB) in patients undergoing heart surgery, including sternotomy. PATIENTS AND METHODS: In this prospective trial, 60 patients were randomly assigned to two groups: transversus (T) or general anesthesia (GA). Patients in the T group received TTPB with GA and 15 mL of 0.25% bupivacaine was administered on either side. Patients in the GA group received TTPB along with GA, but 15 mL saline was injected on either side instead. The patients were followed up postoperatively. The percentage of patients receiving additional opioids, extubation time, intensive care unit (ICU) length, postoperative morphine dose, and adverse events were documented.Entities:
Keywords: adult cardiac surgery; postoperative analgesia; sternotomy; transversus thoracic block
Year: 2021 PMID: 34803399 PMCID: PMC8594901 DOI: 10.2147/LRA.S338685
Source DB: PubMed Journal: Local Reg Anesth ISSN: 1178-7112
Figure 1The block technique. (A) The probe was placed horizontally over the 4th intercostal space to identify the internal mammary artery (IMA) in the horizontal view, (B) then rotated vertically to identify the IMA the in the longitudinal (parasagittal) view. (C) The probe was slide more laterally to identify the transversus thoracic plane, between the internal intercostal (II) and the transversus thoracic (TT) muscles, (D) where the needle (N) tip was adjusted.
Figure 2CONSORT flow diagram.
Demographic Data, Surgical Data and Comorbidities
| N Group (N=30) | T Group (N=30) | Tests | ||
|---|---|---|---|---|
| t/ X2 | P-value | |||
| Female | 12(40%) | 13(43.3%) | 0.069 | 0.793 |
| Male | 18(60%) | 17(56.7%) | ||
| 65.57±5.65 | 65.13±5.59 | 0.299 | 0.766 | |
| II | 22(73.3%) | 20(66.7%) | 0.317 | 0.573 |
| III | 8(26.7%) | 10(33.3%) | ||
| 461.87±1.72 | 460.97±2.22 | 1.756 | 0.084 | |
| 70.27±3.5 | 71.87±4.05 | 1.637 | 0.107 | |
| 145.73±0.74 | 145.47±0.9 | 1.254 | 0.215 | |
| | 7(23.3%) | 10(33.3%) | 0.739 | 0.390 |
| | 5(16.7%) | 3(10%) | 0.577 | 0.448 |
| Aortic valve replacement | 3(10%) | 4(13.3%) | 0.630 | 0.730 |
| Mitral valve replacement | 12(40%) | 14(46.7%) | ||
| CABG (3 grafts) | 15(50%) | 12(40%) | ||
| 55.2±1.19 | 54.77±1.07 | 1.484 | 0.143 | |
| 68.7±1.21 | 69.27±1.23 | 1.801 | 0.077 | |
| 77.6±3.07 | 78.67±2.89 | 1.385 | 0.171 | |
| 1(3.3%) | 2(6.7%) | 0.351 | 0.554 | |
| 23.35±0.95 | 23.23±1.74 | 0.332 | 0.741 | |
Abbreviations: ASA, American Association of Anesthesiologists; CPB, cardiopulmonary bypass; EF, ejection fraction; BMI, body mass index.
Postoperative Pain Scores
| Pain Score | N Group (N=30) | T Group (N=30) | Mann–Whitney Test | ||||
|---|---|---|---|---|---|---|---|
| Z | P-value | ||||||
| At extubation time | (0–0) | 0 | (0–0) | 0 | 0.000 | 1.000 | |
| 8 h | (2–6) | 4 | (0–3) | 0 | 6.188 | <0.001* | |
| 12 h | (3–4) | 4 | (1–4) | 2 | 4.427 | <0.001* | |
| 18 h | (1–2) | 2 | (0–2) | 2 | 1.105 | 0.269 | |
| 24 h | (0–4) | 4 | (0–4) | 2 | 3.960 | <0.001* | |
Notes: Data are median (interquartile range). h, hours. *Mann–Whitney test.
Total Postoperative Morphine Dose, Time to First Analgesic Dose and Percentage of Patients Receiving Extra Doses of Morphine
| N Group (N=30) | T Group (N=30) | |||
|---|---|---|---|---|
| t | P-value | |||
| 13.9±0.66 | 8±0.74 | 32.484 | <0.001* | |
| 5.57±0.5 | 9.07±0.69 | 22.404 | <0.001* | |
| Chi-square test | P-value | |||
| 15 (50%) | 24 (80%) | 5.934 | <0.015* | |
Notes: Postoperative morphine dose and time to first analgesic dose were presented as Mean±SD and compared using Independent t-test, patients receiving extra doses of morphine presented as percentage and compared by chi-square test. *Significant.
Postoperative Hemodynamic Values, Need for Inotropic Support and Ventilation Time
| N Group (N=30) | T Group (N=30) | Tests | ||
|---|---|---|---|---|
| t/ X2 | P-value | |||
| Postoperative mean blood pressure | 80.83±0.75 | 78.57±1.01 | 9.908 | <0.001* |
| Postoperative mean pulse rate (beats/min) | 96.40±1.00 | 94.63±0.96 | 6.953 | <0.001* |
| Need for inotropic support | 2(6.7%) | 4(13.3%) | 0.741 | 0.389 |
| Ventilation time (hours) | 11.07±0.64 | 7.50±0.51 | 23.905 | <0.001* |
Notes: All data were presented as Mean±SD and compared using Independent t-test while need for inotropic support presented as percentage and compared using Chi-square test. *Significant.
ICU Stay Length and Postoperative Complications
| N Group (N=30) | T Group (N=30) | Tests | ||
|---|---|---|---|---|
| t/ X2 | P-value | |||
| ICU stay length (days) | 2.40±0.50 | 1.57±0.50 | 6.440 | <0.001* |
| Pneumothorax | 1(3.3%) | 0(0.0%) | 1.017 | 0.313 |
| Hemothorax | 0(0.0%) | 0(0.0%) | 0.000 | 1.000 |
| Postoperative arrythmia | 5(16.7%) | 3(10.0%) | 0.577 | 0.448 |
| Local anesthetic toxicity | 0(0.0%) | 0(0.0%) | 0.000 | 1.000 |
| Anaphylactic shock | 0(0.0%) | 0(0.0%) | 0.000 | 1.000 |
| Skin infection | 0(0.0%) | 3(10.0%) | 3.158 | 0.076 |
Notes: All data were presented as percentage and compared by Chi-square test except for ICU stay length presented as Mean±SD and compared by T-test. *Significant.